Literature DB >> 6775351

Hydroxyl radical involvement in the luminol chemiluminescence from the reaction of arachidonic acid with sheep vesicular gland microsomes.

P J O'Brien, L G Hulett.   

Abstract

The luminol chemiluminescence associated with the reaction between vesicular gland microsomes and arachidonic acid was found to be inhibited by superoxide dismutase, catalase and hydroxyl radical scavengers. It was also found that diethylenetriamine pentaacetic acid caused only slight inhibition. This is interpreted as showing the formation of hydroxyl radicals in a Haber-Weiss reaction and the interaction of luminol with the hydroxyl radicals. The Haber-Weiss catalyst is taken to be heme iron as the luminescence was not inhibited by diethylenetriamine pentaacetic acid. A model system involving lipoxygenase, haematin and arachidonic acid was shown to be similar, the hydroxyl radicals coming from the interaction of haematin with the hydroperoxides, produced from the lipoxygenase-arachidonic acid reaction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775351     DOI: 10.1016/0090-6980(80)90167-7

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  4 in total

1.  [The antioxidative chromane structure of alpha-tocopherol protects against the consequences of arachidonic acid release in the pulmonary vascular bed (author's transl)].

Authors:  H Wolf; W Seeger; G Stähler; H Neuhof; L Róka
Journal:  Klin Wochenschr       Date:  1981-05-04

2.  Alloxan-induced luminol luminescence as a tool for investigating mechanisms of radical-mediated diabetogenicity.

Authors:  K Grankvist
Journal:  Biochem J       Date:  1981-12-15       Impact factor: 3.857

3.  Effect of hydrogen peroxide on prostaglandin production and cellular integrity in cultured porcine aortic endothelial cells.

Authors:  A R Whorton; M E Montgomery; R S Kent
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

4.  Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice.

Authors:  D Minc-Golomb; H Knobler; Y Groner
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.